Patent ID: 9248153
Filing Date: 2016-02-02
CPC Classification: A61K,A61L,A61P,G01N

Claim Text:
1. A method of treating a wound, the method comprising administering to a wound a composition comprising living dermal fibroblast cells having a wound healing phenotype characterized by: (i) the cells of the composition exhibiting, at less than 14 days, a 2.08 to 48,200-fold higher level of expression of apolipoprotein D (ApoD), a 694 to 662,000-fold higher level of expression of matrix metalloprotease 2 (MMP2), a 33.7 to 43,300-fold higher level of expression of collagen 3a1 (Coll3a1), and a 20.2 to 121,000-fold higher level of expression of smooth muscle actin (SMA), relative to the expression level of Ribosomal protein L32 (RPL32); or (ii) 75-99% of the cells of the composition having a banding pattern of polymerase chain reaction (PCR) products resulting from differential display identical or similar to that shown in wherein the wound is treated.